Literature DB >> 3710002

In vitro cholesterol gallstone dissolution after fragmentation with shock waves.

M Neubrand, T Sauerbruch, F Stellaard, G Paumgartner.   

Abstract

In order to test whether shock wave fragmentation of human gallstones increases their dissolution rates in a bile acid-lecithin solution, we carried out in vitro experiments. Stones comparable in size, weight and cholesterol content (86%) from the same human gallbladder were disintegrated by shock waves. A glycoursodeoxycholic acid (GUDC)-lecithin solution served as solvent. After 10 days incubation in this solvent, intact stones had lost only 4% of their cholesterol. This value increased to 92% after disintegration of the stones by 300 shock wave discharges. Fragments with a size of less than 2 mm had lost 55% of their cholesterol after day 1 and 99% after day 10. A large stone fragment cleaved off by shock waves lost much more cholesterol (42% after 10 days) than an intact untreated stone (4% after 10 days) comparable in size, weight and cholesterol content. These data show that shock wave lithotripsy of cholesterol gallstones considerably accelerates their dissolution rate in a GUDC-lecithin solvent, the desirable fragment size being 2 mm or less. However, even large fragments may lose much more cholesterol than comparable intact stones as a result of changes in surface structure as documented by scanning electron microscopy. The experiments favor the concept of a combined treatment of gallbladder stones by extracorporeally generated shock waves and bile salt therapy.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3710002     DOI: 10.1159/000199310

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  9 in total

1.  Aggressive extracorporeal shock wave lithotripsy of gall bladder stones within wider treatment criteria: fragmentation rate and early results.

Authors:  G Meiser; M Heinerman; G Lexer; O Boeckl
Journal:  Gut       Date:  1992-02       Impact factor: 23.059

2.  Repeated piezoelectric lithotripsy for gallstones with and without ursodeoxycholic acid dissolution: a multicenter study.

Authors:  Y Tsuchiya; F Ishihara; G Kajiyama; S Nakazawa; M Otho; H Tanimura; Y Akura; M Harada; M Hihara; Y Kawai
Journal:  J Gastroenterol       Date:  1995-12       Impact factor: 7.527

3.  Fragmentation of biliary calculi by means of extracorporeally generated piezoelectric shock waves.

Authors:  C Ell; W Kerzel; H Langer; N Heyder; E Foerster; W Domschke
Journal:  Dig Dis Sci       Date:  1989-07       Impact factor: 3.199

4.  In vitro study to elucidate the physical laws concerning the fragmentation of both solitary and multiple artificial stones.

Authors:  H Lobentanzer; M Neubrand; H Hermeking; T Sauerbruch
Journal:  Clin Investig       Date:  1993-11

5.  Biliary stones: treatment by shock-wave lithotripsy.

Authors:  M Sackmann; T Sauerbruch; M Delius; J Holl; W Brendel; G Paumgartner
Journal:  Surg Endosc       Date:  1988       Impact factor: 4.584

6.  In vitro comparison of different gall stone dissolution solvents.

Authors:  H Vergunst; O T Terpstra; H G Nijs; G Steen
Journal:  Gut       Date:  1991-02       Impact factor: 23.059

7.  Combined treatment of symptomatic gallbladder stones by extracorporeal shock-wave lithotripsy (ESWL) and instillation of methyl tert-butyl ether (MTBE).

Authors:  J Holl; T Sauerbruch; M Sackmann; J Pauletzki; G Paumgartner
Journal:  Dig Dis Sci       Date:  1991-08       Impact factor: 3.199

Review 8.  Extracorporeal shockwave lithotripsy of gallstones. Possibilities and limitations.

Authors:  H Vergunst; O T Terpstra; K Brakel; J S Laméris; M van Blankenstein; F H Schröder
Journal:  Ann Surg       Date:  1989-11       Impact factor: 12.969

9.  Extracorporeal shock-wave lithotripsy of bile duct calculi. An interim report of the Dornier U.S. Bile Duct Lithotripsy Prospective Study.

Authors:  K I Bland; R S Jones; J W Maher; P B Cotton; T C Pennell; J R Amerson; J L Munson; G Berci; G J Fuchs; L W Way
Journal:  Ann Surg       Date:  1989-06       Impact factor: 12.969

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.